RESÚMENES MARZO 2007

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Haga un click en la información del journal para acceder al resúmen)

 

Clinical Practice Guidelines for the Management of Anxiety Disorders

Can J Psychiatry, Vol 51, Suppl 2, July 2006

TEXTO GRATUITO

 

Clinical Practice Guidelines for the Treatment of Depressive Disorders. Medications and Other Biological Treatments

Can J Psychiatry, Vol 51, Suppl 2, July 2006

 TEXTO GRATUITO

 

Clinical Practice Guidelines for the Treatment of Depressive Disorders. Combining Psychotherapy and Pharmacotherapy

Can J Psychiatry, Vol 51, Suppl 2, July 2006

 TEXTO GRATUITO

 

Obsessive-Compulsive Disorder and Obsessive-Compulsive Spectrum Disorders: Diagnostic and Dimensional Issues

Eric Hollander, Suah Kim, Sumant Khanna, and Stefano Pallanti

CNS Spectr. 2007;12:2(Suppl 3):5-13

TEXTO GRATUITO

 

Neurobiology of Obsessive-Compulsive Disorder: Serotonin and Beyond

Herman G.M. Westenberg, Naomi A. Fineberg, and Damiaan Denys

CNS Spectr. 2007;12:2(Suppl 3):14-27

TEXTO GRATUITO

 

Treatment of Obsessive-Compulsive Disorder

Dan J. Stein, Jonathan C. Ipser, David S. Baldwin, and Borwin Bandelow

CNS Spectr. 2007;12:2(Suppl 3):28-35

TEXTO GRATUITO

 

OCD. Consensus Statement

Joseph Zohar, Eric Hollander, Dan J. Stein, Herman G. M. Westenberg, and the Cape Town Consensus Group, David S. Baldwin, Borwin Bandelow, Donald W. Black, Pierre Blier, Naomi A. Fineberg, Martine F. Flament, Dan Geller, Sumant Khanna, Juan J. Lopez-Ibor, Stefano Pallanti

CNS Spectr. 2007;12:2(Suppl 3):59-63

TEXTO GRATUITO

 

Triple reuptake inhibitors: What to expect from ‘mega-antidepressants’

Amanda M. Shaw, Mona Boules, Elliott Richelson

Curr Psychiatry. Vol. 6, No. 3 / March 2007

TEXTO GRATUITO

 

Impulsivity and bipolar disorder

P. Najt, J. Perez, M. Sanches, M. A.M. Peluso, D. Glahn and J.C. Soares

European Neuropsychopharmacology. Volume 17, Issue 5, April 2007, Pages 313-320

 

Proposed Coverage Decision Memorandum for Vagus Nerve Stimulation for Treatment of Resistant Depression

USA Medicare Analysis. February 5, 2007

TEXTO GRATUITO

 

FDA Executive Summary on Submission Data of TMS System for Major Depressive Disorder (MDD)

FDA Executive Summary February 2007

TEXTO GRATUITO

 

The association of depression and anxiety with medical symptom burden in patients with chronic medical illness

Wayne Katon, Elizabeth H.B. Lin and Kurt Kroenke

General Hospital Psychiatry. Volume 29, Issue 2, March-April 2007, Pages 147-155

 

Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression

Gartlehner G, Hansen RA, Thieda P, DeVeaugh-Geiss AM, Gaynes BN, Krebs EE, Lux LJ, Morgan LC, Shumate JA, Monroe LG, Lohr KN

Agency for Healthcare Research and Quality (AHRQ). February 2007. Comparative Effectiveness Review. Number 7

TEXTO GRATUITO

 

Types of Depression More Frequent in Bipolar than in Unipolar Affective Illness: Results of the Polish DEP-BI Study
Janusz K. Rybakowski, Aleksandra Suwalska, Dorota Lojko, Joanna Rymaszewska, Andrzej Kiejna

Psychopathology 2007;40:153-158

 

Folate and depression—a neglected problem

Simon N. Young

J Psychiatry Neurosci 2007;32(2):80-2

TEXTO GRATUITO

 

Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems

Asli Sarandol, Emre Sarandol, Salih Saygin Eker, Selda Erdinc, Ebru Vatansever, Selcuk Kirli

Human Psychopharmacology: Clinical and Experimental. Volume 22, Issue 2, Pages 67 - 73

 

Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection

Kurt Kroenke, Robert L. Spitzer, Janet B.W. Williams, Patrick O. Monahan, and Bernd Löwe

Ann Internal Med 2007 | Volume 146 Issue 5 | Pages 317-325

 

Prevalence and Distribution of Major Depressive Disorder in African Americans, Caribbean Blacks, and Non-Hispanic Whites. Results From the National Survey of American Life

David R. Williams, Hector M. González, Harold Neighbors, Randolph Nesse, Jamie M. Abelson, Julie Sweetman, James S. Jackson

Arch Gen Psychiatry. 2007;64:305-315

 

Factors Influencing Glycemic Control in Type 2 Diabetes During Acute- and Maintenance-Phase Treatment of Major Depressive Disorder With Bupropion

Patrick J. Lustman, Monique M. Williams, Gregory S. Sayuk, Billy D. Nix and Ray E. Clouse

Diabetes Care 30:459-466, 2007
TEXTO GRATUITO

 

Hypercortisolemic depression is associated with the metabolic syndrome in late-life

Nicole Vogelzangs, Kristen Suthers, Luigi Ferrucci, Eleanor M. Simonsick, Alessandro Ble, Matthew Schrager, Stefania Bandinelli, Fulvio Lauretani, Sandra V. Giannelli and Brenda W. Penninx

Psychoneuroendocrinology. Volume 32, Issue 2, February 2007, Pages 151-159

 

Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram

Christophe Lançon;  Patrice Verpillat;  Lieven Annemans;  Nicolas Despiegel ; Clément François

International Journal of Psychiatry in Clinical Practice, Volume 11, Issue 1 2007 , pages 44 - 52

 

Preliminary Evidence of Riluzole Efficacy in Antidepressant-Treated Patients with Residual Depressive Symptoms

Gerard Sanacora, Steven F. Kendell, Yael Levin, Arthur A. Simen, Lisa R. Fenton, Vladimir Coric and John H. Krystal

Biological Psychiatry. Volume 61, Issue 6, 15 March 2007, Pages 822-825

 

Topiramate effects on the EEG and alertness in healthy volunteers: A different profile of antiepileptic drug neurotoxicity
Salinsky M, Storzbach D, Oken B, Spencer D

Epilepsy Behav. 2007 Mar 2; [Epub ahead of print]

The spectra of neurasthenia and depression: course, stability and transitions

ORIGINAL PAPER

The spectra of neurasthenia and depression: course, stability and transitions

Alex Gamma, Jules Angst, Vladeta Ajdacic, Dominique Eich and Wulf Rössler

European Archives of Psychiatry and Clinical Neuroscience. Volume 257, Number 2 / March, 2007:120-127

 

Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites
Miia Turpeinen, Niina Koivuviita, Ari Tolonen, Petri Reponen, Stefan Lundgren, Jouko Miettunen, Kaj Metsärinne, Anders Rane, Olavi Pelkonen, Kari Laine
British
Journal of Clinical Pharmacology (OnlineEarly Articles).

 

Oral Contraceptives Induce Lamotrigine Metabolism: Evidence from a Double-blind, Placebo-controlled Trial
Jakob Christensen, Vaiva Petrenaite, Jørn Atterman, Per Sidenius, Inger Öhman, Torbjørn Tomson, Anne Sabers
Epilepsia 2007; 48 (3), 484–489

A Comparative Pharmacokinetic Study in Healthy Volunteers of the Effect of Carbamazepine and Oxcarbazepine on CYP3A4
Astrid-Helene Andreasen, Kim Brøsen, Per Damkier
Epilepsia 2007;48 (3), 490–496

Teratogenesis of sodium valproate

Duncan, Susan

Current Opinion in Neurology. 20(2):175-180, April 2007

Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: Post hoc analysis of patients treated with olanzapine or lithium

John P. Houston, Ilya A. Lipkovich, Jonna Ahl, Matthew D. Rotelli, Robert W. Baker and Charles L. Bowden

Journal of Psychiatric Research. Volume 41, Issue 7, October 2007, Pages 616-621

 

Safety and Efficacy of Oral Escitalopram as Continuation Treatment of Intravenous Citalopram in Patients with Major Depressive Disorder
Laurent Schmitt, Brigitte Tonnoir, Christophe Arbus
Neuropsychobiology 2006;54:201-207

 

Safety and Efficacy of s-Citalopram in Patients with Co-Morbid Major Depression and Diabetes Mellitus
Jay D. Amsterdam, Justine Shults, Nancy Rutherford, Stanley Schwartz
Neuropsychobiology 2006;54:208-214

 

Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients

Marco Bortolomasi, Alessandra Minelli, Giorgio Fuggetta, Michele Perini, Sandra Comencini, Antonio Fiaschi and Paolo Manganotti

Psychiatry Research. Volume 150, Issue 2, 30 March 2007, Pages 181-186

 

Lithium Treatment Reduces Suicide Risk in Recurrent Major Depressive Disorder

Francesca Guzzetta, Leonardo Tondo, Franca Centorrino, and Ross J. Baldessarini

J Clin Psychiatry 2007;68:380-383

 

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

Pierre Blier, Martin B. Keller, Mark H. Pollack, Michael E. Thase, John M. Zajecka, and David L. Dunner

J Clin Psychiatry 2007;68(3):e06

 

Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy
HIDEKI AZUMA, AKIKO FUJITA, KIYOE SATO, KEIKO ARAHATA, KAZUYUKI OTSUKI, MIKI HORI, YOSHIHITO MOCHIDA, MEGUMI UCHIDA, TOMOKO YAMADA, TATSUO AKECHI, TOSHI A. FURUKAWA
Psychiatry and Clinical Neurosciences 2007; 61 (2), 168–173

Unipolar versus bipolar depression: clues toward predicting bipolarity disorder

T. BenAbla

L’Encephale. Vol 32 - N° 6 - Décembre 2006 : 962 - 965

Depressive symptoms in the very old living alone: prevalence, incidence and risk factors

Kenneth Wilson, Patricia Mottram, Andrew Sixsmith

International Journal of Geriatric Psychiatry. Volume 22, Issue 4, Pages 361 - 366

 

An update on the pharmacological treatment of obsessive-compulsive disorder

Leonardo F Fontenelle, Antonio L Nascimento, Mauro V Mendlowicz, Roseli G Shavitt & Marcio Versiani

Expert Opinion on Pharmacotherapy. April 2007, Vol. 8, No. 5, Pages 563-583

 

Oxcarbazepine in bipolar disorder: a critical review of the literature

Marianna Mazza, Marco Di Nicola, Giovanni Martinotti, Colombo Taranto, Gino Pozzi, Gianluigi Conte, Luigi Janiri, Pietro Bria & Salvatore Mazza

Expert Opinion on Pharmacotherapy. April 2007, Vol. 8, No. 5, Pages 649-656

 

Hormonal therapy and depression: Are we overlooking an important therapeutic alternative?

Marie-Laure Ancelin, Jacqueline Scali and Karen Ritchie

Journal of Psychosomatic Research. Volume 62, Issue 4, April 2007, Pages 473-485

 

Impact of Depression and its Treatment on the Bones of Growing Children

Elizabeth B. Weller, Ronald A. Weller, MD, Angelica L. Kloos, Stacie Hitchcock, Woo J. Kim, and Babette Zemel

Current Psychiatry Reports 2007, 9:94-98

 

Antenatal thyroid correlates of postpartum depression

Cort A. Pedersen, Jacqueline L. Johnson, Susan Silva, Robertas Bunevicius, Samantha Meltzer-Brody, Robert M. Hamer and Jane Leserman

Psychoneuroendocrinology. Volume 32, Issue 3, April 2007, Pages 235-245

 

Hypothalamic–pituitary-end organ function in women with bipolar depression

Natalie L. Rasgon, Heather A. Kenna, Ma-Li Wong, Peter C. Whybrow and Michael Bauer

Psychoneuroendocrinology. Volume 32, Issue 3, April 2007, Pages 279-286

 

Longitudinal prevalence and determinants of early mood disorder post-stroke

B.S. Townend, S. Whyte, T. Desborough, D. Crimmins, R. Markus, C. Levi and J.W. Sturm

Journal of Clinical Neuroscience. Volume 14, Issue 5, May 2007, Pages 429-434

 

Anxiety and depressive disorders in 4 425 long term benzodiazepine users in general practice

A. Pélissolo, F. Maniere, B. Boutges, M. Allouche, C. Richard-Berthe, E. Corruble

L’Encephale. Vol 33 - N° 1 - Février 2007: 32 - 38

Validity of vascular depression as a specific diagnostic : a review

J. Thuile, C. Even, J.-D. Guelfi

L’Encephale. Vol 33 - N° 1 - Février 2007: 39 - 48

Pharmacological treatment of generalized anxiety disorders : rationale and limitations

J.-P. Boulenger, D. Capdevielle

L’Encephale. Vol 33 - N° 1 - Février 2007 : 84 - 94

The clinical pharmacokinetics of escitalopram
Rao N

Clin Pharmacokinet. 2007;46(4):281-90

The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression

André Tadi, Matthias J. Müller, Dan Rujescu, Ralf Kohnen, Hans H. Stassen, Norbert Dahmen, Armin Szegedi

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2006; Volume 144B, Issue 3, Pages 325 - 331

 

Quetiapine dosage in bipolar disorder episodes and mixed states

Yasser Khazaal, Sophie Tapparel, Anne Chatton, Stephane Rothen, Martin Preisiga and Daniele Zullino

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 31, Issue 3, 13 April 2007, Pages 727-730